Benign fibrous histiocytoma of larynx
Journal Title: Medical Journal Armed Forces - Year 2017, Vol 73, Issue 1
Abstract
Benign fibrous histiocytoma (BFH) is a benign neoplasm of mesenchymal origin composed of histiocytes and fibroblasts. It is a common neoplasm found in the sun-exposed skin of extremities and rarely presents as a non-cutaneous lesion especially in the head and neck. We report the clinical and pathological aspects of a rare case of BFH of the larynx treated at our centre.
Authors and Affiliations
Satish Nair
Keywords
Related Articles
- EP ID EP637427
- DOI 10.1016/j.mjafi.2015.10.005
- Views 81
- Downloads 0
Sclerosing stromal cell tumor of ovary
Sclerosing Stromal-Cell Tumor (SST) is a rare, benign sex-cord stromal ovarian neoplasm. Most patients present with menstrual irregularities, abdominal or pelvic mass and associated discomfort or pain. Some cases also pr...
Bacterial colonization of peripheral intravenous cannulas in a tertiary care hospital: A cross sectional observational study
Background: The use of intravenous (IV) cannulas is an integral part of patient care in hospitals. These intravenous cannulas are a potential route formicroorganisms to enter the blood stream resulting in a variety of lo...
A descriptive study of clinico-hematological profile of megaloblastic anemia in a tertiary care hospital
Background: Megaloblastic Anemia (MA) is a relatively common disease, yet the data on prevalence of MA remains scarce. This study was conducted to study the prevalence and clinico-hematological profile of MA. Methods: Th...
To evaluate the safety and efficacy of the TVT-Secur procedure in the treatment of stress urinary incontinence in women
Background: The prevalence of stress urinary incontinence (SUI) in the middle-aged Indian women is around 16%. The use of transvaginal tapes (TVTs) has revolutionised the surgical management of SUI. Patients who undergo...
Flow cytometric detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by using ‘‘MRD lite’’ panel
Background: Normal B lymphoid precursors that express CD19, CD10, and/or CD34 are highly sensitive to corticosteroids and after two weeks of remission-induction therapy, they form less than 0.01% of the bone marrow popul...